| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.55 | 0.06 |